{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:17:45Z","timestamp":1767921465208,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1124\/dmd.31.3.319","type":"journal-article","created":{"date-parts":[[2003,2,12]],"date-time":"2003-02-12T19:57:36Z","timestamp":1045079856000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans"],"prefix":"10.1016","volume":"31","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Imbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9ryam","family":"Jardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Charles","family":"Gantier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Dromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"France","family":"Mentre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludy","family":"van Beijsterveldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Singlas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.31.3.319_bib1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1128\/AAC.44.5.1159-1162.2000","article-title":"SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum (\u201cRamichloridium mackenzieie\u201d).","volume":"44","author":"Al-Abdely","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.31.3.319_bib2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/infdis\/169.4.760","article-title":"Salmonella typhimurium induces expression of P glycoprotein (multidrug resistance 1 gene product) in a promonocytic cell line chronically infected with human immunodeficiency virus type 1.","volume":"169","author":"Andreana","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1124\/dmd.31.3.319_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01062139","article-title":"Testing for the equality of area under the curves when using destructive measurement techniques.","volume":"16","author":"Bailer","year":"1988","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/dmd.31.3.319_bib4","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1128\/iai.60.9.3682-3688.1992","article-title":"Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonisation.","volume":"60","author":"Blasi","year":"1992","journal-title":"Infect Immun"},{"key":"10.1124\/dmd.31.3.319_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2990.1999.00188.x","article-title":"Evidence of blood-brain barrier dysfunction in human cerebral malaria.","volume":"25","author":"Brown","year":"1999","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1124\/dmd.31.3.319_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1023\/A:1018892811980","article-title":"Enhanced antinociception of the model opioid peptide [D-penicillamine2,5] enkephaline by P-glycoprotein modulation.","volume":"16","author":"Chen","year":"1999","journal-title":"Pharm Res (NY)"},{"key":"10.1124\/dmd.31.3.319_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0090-9556(24)15144-6","article-title":"Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes.","volume":"28","author":"Choo","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.3.319_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/38.9.1974900","article-title":"Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.","volume":"38","author":"Cordon-Cardo","year":"1990","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/dmd.31.3.319_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.41.7.1589","article-title":"Effect of severity of meningitis on fungicidal activity of flucytosine combined with fluconazole in a murine model of cryptococcal meningitis.","volume":"41","author":"Ding","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.31.3.319_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1054\/bjoc.2000.1260","article-title":"Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport.","volume":"83","author":"Evers","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1124\/dmd.31.3.319_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues.","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.31.3.319_bib12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1006\/bbrc.1994.1355","article-title":"Mycobacterium tuberculosis induces expression of P-glycoprotein in promonocytic U1 cells chronically infected with HIV type 1.","volume":"199","author":"Gollapudi","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.31.3.319_bib13","series-title":"Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents","first-page":"223","article-title":"The pharmacokinetics of itraconazole in animals and man: an overview","author":"Heykants","year":"1987"},{"key":"10.1124\/dmd.31.3.319_bib14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1211\/0022357011776036","article-title":"Expression and function of P-glycoprotein in rats with carbon tetrachloride-induced acute hepatic failure.","volume":"53","author":"Huang","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/dmd.31.3.319_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/13550289909029748","article-title":"Dissemination of C. noeformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment.","volume":"5","author":"Huffnagle","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1124\/dmd.31.3.319_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00007691-199712000-00001","article-title":"Itraconazole decreases renal clearance of digoxin.","volume":"19","author":"Jalava","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.31.3.319_bib17","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/IAI.69.7.4536-4544.2001","article-title":"Traversal of Candida albicans across human blood-brain barrier in vitro.","volume":"69","author":"Jong","year":"2001","journal-title":"Infect Immun"},{"key":"10.1124\/dmd.31.3.319_bib18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0009-9236(97)90046-1","article-title":"Itraconazole increases plasma concentrations of quinidine.","volume":"62","author":"Kaukonen","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.31.3.319_bib19","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0022-3565(24)29319-8","article-title":"Functional expression of P-glycoprotein in rat brain microglia.","volume":"299","author":"Lee","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.3.319_bib20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/PL00000912","article-title":"From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance.","volume":"58","author":"Litman","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/dmd.31.3.319_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2990.2000.00275.x","article-title":"Blood-brain barrier disruption in simian immunodeficiency virus encephalitis.","volume":"26","author":"Luabeya","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1124\/dmd.31.3.319_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1021\/js970114h","article-title":"Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies.","volume":"97","author":"Mager","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.31.3.319_bib23","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.31.3.319_bib24","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.42.7.1738","article-title":"P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier.","volume":"42","author":"Miyama","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.31.3.319_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/517379","article-title":"High human immunodeficiency virus type I RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis.","volume":"177","author":"Morris","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1124\/dmd.31.3.319_bib26","first-page":"1224","article-title":"Identification of members of the P-glycoprotein multigene family.","volume":"9","author":"Ng","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1124\/dmd.31.3.319_bib27","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2000.18.21.3677","article-title":"Phase I dose-finding and pharmacockinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.","volume":"21","author":"Patnaik","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.31.3.319_bib28","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1200\/JCO.2001.19.12.3130","article-title":"Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin.","volume":"19","author":"Peck","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1124\/dmd.31.3.319_bib29","first-page":"710","article-title":"Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.","volume":"30","author":"Saag","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1124\/dmd.31.3.319_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1086\/320158","article-title":"Successful treatment of Aspergillus brain abscess with itraconazole and interferon-\u03b3 in a patient with chronic granulomatous disease.","volume":"32","author":"Saulsbury","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1124\/dmd.31.3.319_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/dmd.30.5.479","article-title":"Effects of a p-glycoprotein inhibitor on brain and plasma concentrations of anti-human immunodeficiency virus drugs administered in combination in rats.","volume":"30","author":"Savolainen","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.31.3.319_bib32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1248\/bpb.22.1355","article-title":"Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.","volume":"22","author":"Takara","year":"1999","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.31.3.319_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3565(24)38880-9","article-title":"Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.","volume":"295","author":"Tamai","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.31.3.319_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/37.2.2463300","article-title":"Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and cross reactivity of one antibody with a muscle protein.","volume":"37","author":"Thiebaut","year":"1989","journal-title":"J Histochem Cytochem"},{"key":"10.1124\/dmd.31.3.319_bib35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1439-0507.1993.tb00723.x","article-title":"Therapy of experimental meningeal and disseminated cryptococcosis.","volume":"36","author":"Van Cutsem","year":"1993","journal-title":"Mycoses"},{"key":"10.1124\/dmd.31.3.319_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM199707033370103","article-title":"Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome.","volume":"337","author":"Van der Horst","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.31.3.319_bib37","first-page":"1317","article-title":"Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cells in vitro.","volume":"19","author":"Varga","year":"1999","journal-title":"Anticancer Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624026291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624026291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.31.3.319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T15:10:15Z","timestamp":1739891415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624026291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0090955624026291"],"URL":"https:\/\/doi.org\/10.1124\/dmd.31.3.319","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Efflux Inhibition on Brain Uptake of Itraconazole in Mice Infected with Cryptococcus neoformans","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.31.3.319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}